2018 American Transplant Congress Archives - Page 7 of 211

5:30pm-7:30pm: Circulating Follicular Helper T Cells (cTfh) in Renal Transplantation: Utility as Rejection Biomarker

R. Laguna-Goya,¹ A. Utrero-Rico,¹ F. Cano-Romero,¹ E. Gómez-Massa,² D. Arroyo,¹ P. Auñon-Rubio,³ A. Sevillano-Prieto,³ M. Castro-Panete,² A. Andrés,³ E. Paz-Artal.^1,2

Poster Session A: Biomarkers, Immune Monitoring and Outcomes • Hall 4EF

5:30pm-7:30pm: Circulating Wnt Pathway Factors Are Non-Invasive Biomarkers of Transplant Vascular Injury

M. Seifert,¹ A. Malone,² L. Boohaker,¹ J. Gaut,² S. Jain,² D. Brennan,^2,3 R. Mannon.¹

Poster Session A: Biomarkers, Immune Monitoring and Outcomes • Hall 4EF

5:30pm-7:30pm: Clinical Heterogeneity of Early Anamnestic Donor Specific Antibody Responses in Kidney Transplantation

A. Loethen,¹ A. Lichvar,¹ S. Tremblay,¹ A. Shields,^1,2 A. Dao,¹ M. Cardi,² P. Brailey,¹ A. Girnita,¹ B. Abu Jawdeh,¹ R. Alloway,¹ E. Woodle.¹

Poster Session A: Kidney Acute Antibody Mediated Rejection • Hall 4EF

5:30pm-7:30pm: Clinical Outcomes of Kidney Transplant Recipients Infected with Hepatitis C Virus and Treated with Direct-Acting Antiviral Therapy

M. Alkadi,¹ E. Abuhelaiqa,¹ M. Derbala,² O. Fituri,¹ J. Mahmoud,³ M. Jarman,³ M. Asim,¹ A. Aziz,¹ A. Nauman,¹ A. Hamdi,¹ Y. Medhat,² S. Al Kaabi,² H. Al-Malki.¹

Poster Session A: Kidney Transplant Goes Viral • Hall 4EF

5:30pm-7:30pm: Clinical Response to Salvage Bortezomib Therapy for Antibody Mediated Rejection and Mixed Acute Rejection in a High Immunologic Risk Renal Transplant Population

A. Lichvar, J. Benken, E. Benedetti.

Poster Session A: Kidney Acute Antibody Mediated Rejection • Hall 4EF

5:30pm-7:30pm: Clinical Significance and Therapeutic Potential of Orosomucoid 1 for Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

H. Higuchi,^1,2 K. Hotta,¹ D. Iwami,¹ J-.J. Jiang,² D. Kamimura,² Y. Arima,² T. Atsumi,² Y. Takada,^1,2 H. Harada,³ M. Murakami,² N. Shinohara.¹

Poster Session A: Biomarkers, Immune Monitoring and Outcomes • Hall 4EF

5:30pm-7:30pm: Clinical Significance of BK Virus-Specific ELISPOT Assay in Kidney Transplant Recipients

J. Chang,^1,2 H. Bae,³ K. Park,³ H. Lee,³ B. Choi,^1,2 C. Park,^1,2 C. Yang,^1,2 Y. Kim,^1,2 E-.J. Oh,^1,4 B. Chung.^1,2

Poster Session A: Kidney Transplant Goes Viral • Hall 4EF

5:30pm-7:30pm: Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation

S. Parajuli, R. Redfield, F. Aziz, N. Garg, M. Mohamed, W. Zhong, T. Ellis, A. Djamali, D. Mandelbrot.

Poster Session A: Kidney Acute Antibody Mediated Rejection • Hall 4EF

5:30pm-7:30pm: Clinical Validation of a Novel ELISpot-Based In Vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients

B. Banas,¹ D. Steubl,² L. Renders,² D. Chittka,¹ M. Banas,¹ T. Wekerle,³ M. Koch,⁴ O. Witzke,⁵ A. Muehlfeld,⁶ C. Sommerer,⁷ A. Habicht,⁸ C. Hugo,⁹ T. Huenig,¹⁰ M. Lindemann,⁵ T. Schmidt,¹¹ A. Rascle,¹¹ S. Barabas,¹¹ L. Deml,¹¹ R. Wagner,^1,11 B. Kraemer,¹² B. Krueger.¹²

Poster Session A: Kidney Transplant Goes Viral • Hall 4EF

5:30pm-7:30pm: Cold Ischemia Time is an Important Risk Factor for Post-Liver Transplant Prolonged Length of Stay

E. Pan, D. Yoeli, N. Galvan, M. Kueht, R. Cotton, C. O'Mahony, J. Goss, A. Rana.

Poster Session A: Liver: MELD, Allocation and Donor Issues (DCD/ECD) • Hall 4EF